title: Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
abstract: Whereas gp120 CD4-induced structures have been largely documented and at least in part elucidated by crystallization, information about gp120 coreceptor-induced structures remains incomplete despite numerous studies. In this work, mutations were carried out in a selected internal region of HIV-1/YU2 gp120, proximal to the CD4-binding site, because of its highly conserved nature among retroviruses and its high structural stability. The targeted residues, belonging to the beta16/beta17 beta-hairpin, modulate gp120 binding to CD4 and gp120-CD4 complex binding to CCR5. Thus, it appears that this gp120 structure acts as a hinge between the CD4-binding site and the putative coreceptor binding structure. Substitution of amino acid residues like E381A did not affect gp120 binding to CD4 and did not induce significant structural changes in gp120, as demonstrated by epitope analysis, BIACORE analysis, and circular dichroism. Nevertheless, E381 has a critical influence on the maintenance of CCR5 coreceptor binding by forming a salt bridge with K207. Another important element of the beta-hairpin in this interaction is the probable hydrophobic link between F383 and I420. Altogether, these results suggest that the beta-hairpin structure likely governs interactions between the surface of gp120 with native CCR5 or the CCR5 amino-terminal domain (CCR5-Nt). The mutations within the beta-hairpin had a direct effect on the proximal surface of the bridging sheet, the putative CCR5 surface, and the gp120 YU2 HIV-1-CD4 binding site. These results on the gp120-CCR5-Nt binding mechanism contribute to our understanding of CCR5 and HIV-1 gp120 association and HIV-1 entry; they may also contribute to designing novel inhibitors.
authors.affiliation: Laboratoire d'Immunologie Rétrovirale et Moléculaire, Institut Français de Recherches pour le Développement (IRD), UR 034, 240 Av. Emile Jeanbrau, Etablissement Français du Sang, 34094, Montpellier, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Mechulam
authors.forename: Martine
authors.initials: M
authors.lastname: Cerutti
authors.forename: Martine
authors.initials: M
authors.lastname: Pugnière
authors.forename: Dorothée
authors.initials: D
authors.lastname: Missé
authors.forename: Johanna
authors.initials: J
authors.lastname: Gajardo
authors.forename: Françoise
authors.initials: F
authors.lastname: Roquet
authors.forename: James
authors.initials: J
authors.lastname: Robinson
authors.forename: Francisco
authors.initials: F
authors.lastname: Veas
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal; D015704:CD4 Antigens / Q000378:metabolism; D002942:Circular Dichroism; D005434:Flow Cytometry; D015699:HIV Envelope Protein gp120 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D015497:HIV-1 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D011485:Protein Binding; D017433:Protein Structure, Secondary; D019713:Receptors, CCR5 / Q000378:metabolism*; D017385:Sequence Homology
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D019713:Receptors, CCR5